Wasatch Advisors LP Purchases 148,446 Shares of Billiontoone, Inc. $BLLN

Wasatch Advisors LP raised its position in Billiontoone, Inc. (NASDAQ:BLLN) by 40.2% during the second quarter, according to its most recent filing with the SEC. The firm owned 518,084 shares of the company’s stock after purchasing an additional 148,446 shares during the period. Wasatch Advisors LP’s holdings in Billiontoone were worth $62,160,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of BLLN. Adams Street Partners LLC acquired a new stake in shares of Billiontoone during the fourth quarter worth $140,063,000. Baillie Gifford & Co. acquired a new position in Billiontoone in the fourth quarter valued at $103,786,000. Price T Rowe Associates Inc. MD acquired a new position in Billiontoone in the fourth quarter valued at $39,717,000. JPMorgan Chase & Co. bought a new stake in Billiontoone during the fourth quarter valued at $32,078,000. Finally, Emerald Advisers LLC boosted its position in Billiontoone by 26.8% during the first quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock valued at $18,911,000 after acquiring an additional 50,613 shares during the last quarter.

Insider Buying and Selling

In related news, insider Shan Riku Sakakibara sold 8,000 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $110.00, for a total transaction of $880,000.00. Following the transaction, the insider directly owned 208,000 shares of the company’s stock, valued at $22,880,000. This trade represents a 3.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO David Tsao sold 20,000 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $102.27, for a total transaction of $2,045,400.00. Following the transaction, the chief technology officer owned 1,000 shares in the company, valued at approximately $102,270. This trade represents a 95.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 202,049 shares of company stock valued at $23,496,861 in the last 90 days. Insiders own 50.22% of the company’s stock.

Wall Street Analysts Forecast Growth

BLLN has been the subject of several research analyst reports. Guggenheim began coverage on Billiontoone in a research report on Monday, June 29th. They issued a “buy” rating and a $125.00 price objective for the company. Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings raised Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 23rd. JPMorgan Chase & Co. lowered their target price on Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a report on Thursday, August 6th. Finally, BTIG Research dropped their price target on Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, August 6th. Six investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $126.71.

Billiontoone Price Performance

Shares of NASDAQ:BLLN opened at $97.94 on Wednesday. Billiontoone, Inc. has a twelve month low of $61.96 and a twelve month high of $150.44. The firm has a market capitalization of $4.50 billion and a price-to-earnings ratio of 139.91. The stock’s 50 day moving average is $116.72 and its 200-day moving average is $94.50. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.15. The firm had revenue of $109.45 million during the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. Sell-side analysts forecast that Billiontoone, Inc. will post 0.92 EPS for the current fiscal year.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.